516481-36-0 Usage
Chemical structure
2-(4'-Chlorobiphenyl-4-yl)-1H-benzimidazole-5-carboxylic acid consists of a benzimidazole ring and a carboxylic acid group, with a chlorine-substituted biphenyl group attached to the benzimidazole ring.
Benzimidazole ring
A heterocyclic aromatic ring containing two nitrogen atoms, which contributes to the compound's diverse biological activities.
Carboxylic acid group
A functional group consisting of a carbonyl group (C=O) and a hydroxyl group (OH) attached to the same carbon atom, which can participate in various chemical reactions and form hydrogen bonds.
Chlorine-substituted biphenyl group
A chlorine atom attached to a biphenyl group (two phenyl rings connected by a single bond), which may influence the compound's pharmacological properties and applications.
Pharmaceutical applications
The compound may have potential uses in the development of drugs due to the biological activities of benzimidazole derivatives, such as antifungal, antibacterial, and anticancer properties.
Industrial applications
The compound could be used as a building block for the synthesis of other complex organic compounds or as a component in drug delivery systems due to the presence of the carboxylic acid group.
Further research and development
The full potential of this chemical compound in various fields may be revealed through additional research, development, and exploration of its properties and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 516481-36-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,1,6,4,8 and 1 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 516481-36:
(8*5)+(7*1)+(6*6)+(5*4)+(4*8)+(3*1)+(2*3)+(1*6)=150
150 % 10 = 0
So 516481-36-0 is a valid CAS Registry Number.
516481-36-0Relevant academic research and scientific papers
Substituted benzimidazoles and imidazo-[4,5]-pyridines
-
, (2008/06/13)
2-Aryl substituted benzimidazoles and imidazo[4,5]pyridines are disclosed as inhibitors of Cds1 and useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer.
